Back to Search
Start Over
Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors
- Source :
- Biomedicine & Pharmacotherapy, Vol 110, Iss, Pp 145-154 (2019)
- Publication Year :
- 2018
-
Abstract
- Background and purpose: Insulin resistance (IR) and obesity predispose diseases such as diabetes, cardiovascular and neurodegenerative disorders. Beta-caryophyllene (BCP), a natural sesquiterpene, exerts neuroprotective, anxiolytic and antidepressant effects via its selective agonism to cannabinoid receptor 2 (CB2R). BCP was shown to have an anti-diabetic effect, however, the implication of CB2R is yet to be elucidated. A link between CB2R agonism and PPAR-γ activation has been discussed, but the exact mechanism is not well-defined. This study was designed to examine the role of BCP in improving diet-induced metabolic (insulin resistance), neurobehavioral (anxiety, depression and memory deficit), and neurochemical (oxidative, inflammatory and neurotrophic factor) alterations in the prefrontal cortex of obese rats’ brain. The involvement of CB2R and/or PPAR-γ dependent activity was also investigated. Experimental approach: Male Wistar rats were fed a high fat/fructose diet (HFFD) for 12 weeks to induce IR and obesity. Rats were treated with BCP for the last 4 weeks. Either CB2R antagonist AM630 or PPAR-γ antagonist BADGE was administered before BCP treatment to study the mechanism of BCP actions. Key results: Beta-caryophyllene alleviated HFFD-induced IR, oxidative-stress, neuroinflammation and behavioral changes. The anxiolytic, anti-oxidant and anti-inflammatory effects of BCP were mediated by both PPAR-γ and CB2R. The effects of BCP on glycemic parameters seem to be CB2R-dependent with the non-significant role of PPAR-γ. Furthermore, BCP-evoked antidepressant and memory improvement are likely mediated only via CB2R, mainly by upregulation of PGC-1α and BDNF. Conclusion: This study suggests the potential effect of BCP in treating HFFD-induced metabolic and neurobehavioral alterations. BCP seems to activate PPAR-γ in a ligand-independent manner, via upregulation and activation of PGC-1α. The BCP activation of PPAR--γ seems to be CB2R-dependent.
- Subjects :
- 0301 basic medicine
Male
medicine.medical_specialty
PPAR-γ
Beta-caryophyllene
medicine.drug_class
Peroxisome proliferator-activated receptor
PGC-1α
RM1-950
Fructose
Diet, High-Fat
Anxiolytic
Neuroprotection
Receptor, Cannabinoid, CB2
03 medical and health sciences
0302 clinical medicine
Neurochemical
Insulin resistance
Downregulation and upregulation
Internal medicine
medicine
Cannabinoid receptor type 2
Animals
Obesity
Cannabinoid receptor 2
Rats, Wistar
Maze Learning
Pharmacology
chemistry.chemical_classification
Polycyclic Sesquiterpenes
Memory Disorders
business.industry
Anti-Inflammatory Agents, Non-Steroidal
Antagonist
General Medicine
medicine.disease
Rats
PPAR gamma
Oxidative Stress
030104 developmental biology
Endocrinology
chemistry
High fat/fructose diet
030220 oncology & carcinogenesis
Therapeutics. Pharmacology
business
Sesquiterpenes
Subjects
Details
- ISSN :
- 19506007
- Volume :
- 110
- Database :
- OpenAIRE
- Journal :
- Biomedicinepharmacotherapy = Biomedecinepharmacotherapie
- Accession number :
- edsair.doi.dedup.....36461ee016c1c4801e96c20ea3cfb613